Effectiveness and Safety of Entecavir or Tenofovir in a Spanish Cohort of Chronic Hepatitis B Patients: Validation of the Page-B Score to Predict Hepatocellular Carcinoma

Riveiro-Barciela Mar; Tabernero David; Calleja Jose L.; Lens Sabela; Manzano Maria L.; Gea Rodriguez Francisco; Crespo Javier; Piqueras Belen; Pascasio Juan M.; Comas Carmen; Gutierrez Maria L.; Aguirre Alberto; Suarez Emilio; Garcia-Samaniego Javier; Rivero Miguel; Acero Doroteo; Fernandez-Bermejo Miguel; Moreno Diego; Sanchez-Pobre Pilar; de Cuenca Beatriz; Moreno-Palomares J. J.; Esteban Rafael; Buti Maria

首页> 外文期刊>Digestive Diseases and Sciences >Effectiveness and Safety of Entecavir or Tenofovir in a Spanish Cohort of Chronic Hepatitis B Patients: Validation of the Page-B Score to Predict Hepatocellular Carcinoma

【24h】

Effectiveness and Safety of Entecavir or Tenofovir in a Spanish Cohort of Chronic Hepatitis B Patients: Validation of the Page-B Score to Predict Hepatocellular Carcinoma

机译：恩替卡韦血管在西班牙慢性乙型肝炎患者队列中的有效性和安全性：Page-B评分的验证预测肝细胞癌

获取原文

获取原文并翻译 | 示例

获取外文期刊封面目录资料

开具论文收录证明 >>

文献代查 >>

文献数据库（团队版） >>

页面导航

摘要
著录项
引文网络
相似文献
相关主题

摘要

Long-term antiviral therapy has resulted in viral suppression and biochemical response in chronic hepatitis B, although the risk of hepatocellular carcinoma has not been abolished. The Page-B score could be useful to estimate the probability of HCC.

机译：长期抗病毒治疗导致慢性乙型肝炎病毒抑制和生化反应，尽管肝细胞癌的风险尚未被废除。 Page-B分数可能有助于估计HCC的概率。

著录项

来源
《Digestive Diseases and Sciences》 |2017年第3期|共10页
作者
Riveiro-Barciela Mar; Tabernero David; Calleja Jose L.; Lens Sabela; Manzano Maria L.; Gea Rodriguez Francisco; Crespo Javier; Piqueras Belen; Pascasio Juan M.; Comas Carmen; Gutierrez Maria L.; Aguirre Alberto; Suarez Emilio; Garcia-Samaniego Javier; Rivero Miguel; Acero Doroteo; Fernandez-Bermejo Miguel; Moreno Diego; Sanchez-Pobre Pilar; de Cuenca Beatriz; Moreno-Palomares J. J.; Esteban Rafael; Buti Maria;
展开▼
作者单位

Hosp Univ Vall dHebron Dept Internal Med Liver Unit Passeig Vall Hebron 119-129 Barcelona 08035;

Univ Autonoma Barcelona Passeig Vall Hebron 119-129 Barcelona 08035 Spain;

Inst Salud Carlos III Ctr Invest Biomed Red Enfermedades Hepat &

Digest Madrid Spain;

Inst Salud Carlos III Ctr Invest Biomed Red Enfermedades Hepat &

Digest Madrid Spain;

Hosp Univ 12 octubre Digest Dis Dept Madrid Spain;

Hosp Univ Ramn &

Cajal Digest Dis Dept Madrid Spain;

Hosp Univ Valdecilla Fac Med Gastroenterol &

Hepatol Unit IDIVAL Santander Spain;

Hosp Univ Fuenlabrada Digest Dis Dept Madrid Spain;

Inst Salud Carlos III Ctr Invest Biomed Red Enfermedades Hepat &

Digest Madrid Spain;

Hosp Univ Infanta Sofia Digest Dis Dept San Sebastian Spain;

Hosp Univ Fdn Alcorcon Digest Dis Dept Madrid Spain;

Hosp Univ Severo Ochoa Digest Dis Dept Madrid Spain;

Hosp Univ Virgen Valme Digest Dis Dept Seville Spain;

Inst Salud Carlos III Ctr Invest Biomed Red Enfermedades Hepat &

Digest Madrid Spain;

Hosp Univ Sureste Digest Dis Dept Madrid Spain;

Hosp Univ Girona Dr Josep Trueta Digest Dis Dept Girona Spain;

Hosp San Pedro Alcantara Digest Dis Dept Caceres Spain;

Hosp Univ Mostoles Digest Dis Dept Madrid Spain;

Hosp Clin San Carlos Digest Dis Dept Madrid Spain;

Hosp Infanta Cristina Digest Dis Dept Madrid Spain;

Hosp Gen Segovia Dept Internal Med Segovia Spain;

Hosp Univ Vall dHebron Dept Internal Med Liver Unit Passeig Vall Hebron 119-129 Barcelona 08035;

Hosp Univ Vall dHebron Dept Internal Med Liver Unit Passeig Vall Hebron 119-129 Barcelona 08035;

展开▼
收录信息
原文格式 PDF
正文语种 eng
中图分类消化系及腹部疾病;
关键词
Hepatitis B; Hepatocellular carcinoma; Page-B; Tenofovir; Entecavir; Effectiveness; Safety;

机译：乙型肝炎;肝细胞癌;Page-b;enofovir;Entecavir;有效性;安全;

相似文献

外文文献
中文文献
专利

1. Effectiveness and Safety of Entecavir or Tenofovir in a Spanish Cohort of Chronic Hepatitis B Patients: Validation of the Page-B Score to Predict Hepatocellular Carcinoma [J] . Riveiro-Barciela Mar, Tabernero David, Calleja Jose L., Digestive Diseases and Sciences . 2017,第3期

机译：恩替卡韦血管在西班牙慢性乙型肝炎患者队列中的有效性和安全性：Page-B评分的验证预测肝细胞癌
2. Comparison of tenofovir and entecavir on the risk of hepatocellular carcinoma and mortality in treatment-naive patients with chronic hepatitis B in Korea: a large-scale, propensity score analysis [J] . Lee Sung Won, Kwon Jung Hyun, Lee Hae Lim, Gut: Journal of the British Society of Gastroenterology . 2020,第7期

机译：Tenofovir和Entecavir对韩国慢性乙型肝炎治疗幼虫患者肝细胞癌和死亡率风险的比较：大规模，倾向分析
3. Incidence and predictors of hepatocellular carcinoma in Caucasian chronic hepatitis B patients receiving entecavir or tenofovir [J] . Papatheodoridis George V., Dalekos George N., Yurdaydin Cihan, Journal of Hepatology: The Journal of the European Association for the Study of the Liver . 2015,第2期

机译：接受恩替卡韦或替诺福韦治疗的白种人慢性乙型肝炎患者肝细胞癌的发病率和预测因素
4. Herbal Medicine Containing Aristolochic Acid and the Risk of Hepatocellular Carcinoma in Patients with Hepatitis C Virus Infection: A Nationwide Population-Based Cohort Study in Taiwan [C] . Wen-Chao Ho, Chi-Jen Chen, Yao-Hsu Yang, Joint annual meeting of the International Society of Exposure Science and the International Society for Environmental Epidemiology . 2018

机译：含有马兜铃酸的草药和丙型肝炎病毒感染患者肝细胞癌的风险：台湾全国性人群研究
5. An exploratory study for the discovery of non-invasive hepatocellular carcinoma biomarkers among high-risk hepatitis C virus infected patients. [D] . Abdalla, Moemen. 2009

机译：在高危丙型肝炎病毒感染患者中发现非侵入性肝细胞癌生物标志物的探索性研究。
6. Original research: Comparison of tenofovir and entecavir on the risk of hepatocellular carcinoma and mortality in treatment-naïve patients with chronic hepatitis B in Korea: a large-scale propensity score analysis [O] . Sung Won Lee, Jung Hyun Kwon, Hae Lim Lee, -1

机译：原始研究：替诺福韦和恩替卡韦在韩国未接受过治疗的慢性乙型肝炎患者中对肝细胞癌风险和死亡率的比较：大规模倾向得分分析
7. Entecavir versus tenofovir in patients with chronic hepatitis B: Enemies or partners in the prevention of hepatocellular carcinoma [O] . Sung Won Lee, Jonggi Choi, Seung Up Kim, 2021

机译：Entecavir与替诺福韦患者慢性乙型肝炎：敌人或伴侣预防肝细胞癌

Effectiveness and Safety of Entecavir or Tenofovir in a Spanish Cohort of Chronic Hepatitis B Patients: Validation of the Page-B Score to Predict Hepatocellular Carcinoma

摘要

著录项

引文网络

相似文献

相关主题

期刊订阅